✦ LIBER ✦

Simpson's paradox and calculation of number needed to treat from meta-analysis

✍ Scribed by Christopher J Cates

Book ID: 115008606
Publisher: BioMed Central
Year: 2002
Tongue: English
Weight: 501 KB
Volume: 2
Category: Article
ISSN: 1471-2288
DOI: 10.1186/1471-2288-2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis, Simpson's paradox, and th

Meta-analysis, Simpson's paradox, and the number needed to treat

✍ Douglas G Altman; Jonathan J Deeks 📂 Article 📅 2002 🏛 BioMed Central 🌐 English ⚖ 263 KB

Rhythm vs. rate control of atrial fibril

Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat

✍ Cyrus R. Kumana; Bernard M. Y. Cheung; Giselle T. Y. Cheung; Tori Ovedal; Bjorn 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

PNL8 TRIPTANS IN THE ACUTE TREATMENT OF

PNL8 TRIPTANS IN THE ACUTE TREATMENT OF MIGRAINE: COSTEFFECTIVENESS ANALYSIS BASED ON NUMBER NEEDED TO TREAT AND DOSES NEEDED TO TREAT

✍ A Dugar; PJ Healey; K Weis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Recombinant or urinary follicle-stimulat

Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis

✍ Bolarinde Ola; Spyros Papaioannou; Masoud A Afnan; Nahed Hammadieh; Silas Gimba 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Methods to calculate relative risks, ris

Methods to calculate relative risks, risk differences, and numbers needed to treat from logistic regression

✍ Ralf Bender; Oliver Kuss 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

The place of memantine in the treatment

The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis

✍ Gill Livingston; Cornelius Katona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## Introduction Memantine is currently the only treatment approved for moderately severe to severe Alzheimer's disease (AD). There is still some discussion as to its place in clinical practice and many UK clinicians are discouraged for economic reasons from prescribing it. We adopt a ‘